Back To Search Instructions
Protocols
11 protocols meet the specified criteria
Disease Site: Other Skin
Protocol No.TitleStatus
1100000212Skin Cancer Institute Patient Registry and Tissue BankOpen
1200000229Skin Cancer Prevention Program BiorepositoryOpen
1408448583The Use of In Vivo Confocal Microscopy In Normal and Pathological Cutaneous Lesions Open
1409505107Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated LightOpen
1704383758A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular MelanomaOpen
1706595817A Multicenter, Two Part Open-Label, Phase 1b Clinical Study of CMP-001 Administered Either in Combination with Pembrolizumab or as Monotherapy in Subjects with Advanced MelanomaOpen
1707620366A Phase 1/2 Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination with Ipilimumab or Pembrolizumab in Patients with Metastatic MelanomaOpen
1807738975A Single Arm Phase 2 Study of talimogene laherparepvec in patients with cutaneous squamous cell cancerOpen
PHXE-17-0101-80-15A Phase 2 Study of REGN2810, A Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or were Intolerant of Prior Hedgehog Pathway Inhibitor TherapyOpen
PHXE-17-0117-80-15A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell LymphomaOpen
PHXE-17-0216-10-15EAY131: Molecular Analysis for Therapy Choice (MATCH) Open